1TWI image
Deposition Date 2004-07-01
Release Date 2004-07-27
Last Version Date 2023-08-23
Entry Detail
PDB ID:
1TWI
Keywords:
Title:
Crystal structure of Diaminopimelate Decarboxylase from m. jannaschii in co-complex with L-lysine
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Diaminopimelate decarboxylase
Gene (Uniprot):lysA
Chain IDs:A, B, C, D
Chain Length:434
Number of Molecules:4
Biological Source:Methanocaldococcus jannaschii
Primary Citation
Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic resistance accessory factor
Structure 10 1499 1508 (2002)
PMID: 12429091 DOI: 10.1016/S0969-2126(02)00880-8

Abstact

Cocrystal structures of Methanococcus jannaschii diaminopimelate decarboxylase (DAPDC) bound to a substrate analog, azelaic acid, and its L-lysine product have been determined at 2.6 A and 2.0 A, respectively. This PLP-dependent enzyme is responsible for the final step of L-lysine biosynthesis in bacteria and plays a role in beta-lactam antibiotic resistance in Staphylococcus aureus. Substrate specificity derives from recognition of the L-chiral center of diaminopimelate and a system of ionic "molecular rulers" that dictate substrate length. A coupled-enzyme assay system permitted measurement of kinetic parameters for recombinant DAPDCs and inhibition constants (K(i)) for azelaic acid (89 microM) and other substrate analogs. Implications for rational design of broad-spectrum antimicrobial agents targeted against DAPDCs of drug-resistant strains of bacterial pathogens, such as Staphylococcus aureus, are discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures